Come up with a name for your new list and we'll add to it:
Q Therapeutics raised a round of funding on June 18, 2010. Investors include
Maryland Stem Cell Research Fund.
Q Therapeutics, Inc. is developing glial cell-based therapeutic products for central nervous system disorders in which a disease or injury inhibits normal myelin growth and enzyme performance.…